Ida L. Email & Phone Number

Hong Kong

▪ Liaised and established good relationship with stakeholders including regulatory authorities, hospitals, healthcare professionals, CROs, vendors and other cross-functional teams such as pre-clinical team and administration team to coordinate two global Phase III multi-regional oncology clinical trials (Pexa-Vec & Glufosfamide) and other Phase I to Phase II immune-oncology combination therapy trials in China;▪ Accelerated clinical trial tasks including investigator meetings, Investigational New Drug (IND) applications and submissions, drug imports, writing and review of Protocols, IBs, ICFs, SOPs, presentation materials and other regulatory documents by ensuring effective communication and mediating conflicts; and▪ Monitored pre-clinical oncology projects by keeping schedules, tracking changes and document versions, identifying potential risks and planning for back-up plans, solving issues among cross-functional teams and presenting progress to senior managements.

Hong Kong

▪ Performed extensive review on European Pharmacopoeia, United States Pharmacopeia and guidelines of other regulatory agencies to carefully plan for and drive execution of method development, verification and validation for method-transfer and scale-up of pre-clinical R&D projects for oncology drugs and suggesting Corrective And Preventive Actions (CAPAs); and▪ Provided training and mentoring to junior staff.

Hong Kong

▪ Led a research team and successfully created several prolonged-release drug-coating formulations in only one year under shortage of raw materials and other resources.

Master Of Philosophy - Mphil, Medicine

Bachelor Of Science - Bs, Biology, First Class Honors